In all this randomness and this pandemonium, you and Chidi found each other, and you had a life together. Isn’t that remarkable?” Maybe that’s the closest we can get to an answer. Todd and I built a ...
Aiming to better understand what these risk factors might be, Weisskopf and colleagues set out to explore whether if ALS risk ...
The U.S. House of Representatives has passed legislation that would renew the ACT for ALS, a landmark federal law that supports amyotrophic lateral sclerosis (ALS) research and helps people with the ...
A 19-protein blood panel may help predict ALS symptom onset in mutation carriers. The panel estimated symptom timing with an average error of 1.6 years. This tool could help guide enrollment in ALS ...
ALS-causing NEK1 gene mutations disrupt cellular protein production machinery. Truncated NEK1 protein accumulates in the nucleolus, impairing ribosome biogenesis. This disruption leads to cell death ...
A new genetic study links higher levels of specific fat molecules to increased ALS risk. Fat metabolism in the body was identified as a relevant pathway in ALS susceptibility. The scientists say ...
A new gene therapy for ALS due to SOD1 gene mutations was shown to significantly extend survival in mouse models. This one-time intravenous treatment targets and shuts down production of the toxic ...
What is IPL344 for ALS? IPL344 is being developed by Immunity Pharma as a possible treatment for slowing disease progression in people with amyotrophic lateral sclerosis (ALS). ALS is a progressive ...
While genetics alone do not cause amyotrophic lateral sclerosis (ALS), a large number of genetic mutations have been associated with the neurodegenerative disease. Such mutations can increase a person ...
What is pridopidine for ALS? Pridopidine is an experimental oral therapy that is being tested as a potential treatment for amyotrophic lateral sclerosis (ALS). In ALS, the specialized nerve cells that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results